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Statement of Purpose: Targeted delivery of drugs, 
contrast agents, and cells is highly desirable for an 
increasing number of medical diagnostic and therapeutic 
applications.  Beneficial site-specific effects can be 
enhanced while harmful off-site effects can be minimized.  
Magnetic forces are a promising means of achieving 
targeted delivery.  We have previously demonstrated the 
feasibility of using magnetic attraction to capture and 
retain magnetically-labeled endothelial cells to the surface 
of magnetized vascular stents (Pislaru SV. J Am Coll 
Cardiol. 2006;48:1839-1845).  Targeted delivery of 
autologous endothelial cells to a stented artery may 
enhance healing, mitigate thrombosis and restenosis, and 
improve clinical outcomes.  In the current study, we 
investigate the hypothesis that delivering magnetically-
labeled endothelial cells to a ferromagnetic vascular stent 
within an externally applied magnetic field will enhance 
cell capture when compared to cell delivery in the 
absence of an externally applied magnetic field. 
Methods: Ferromagnetic vascular stents were 
manufactured from 2205 duplex stainless steel.  This 
material was chosen based on its magnetizability, 
biocompatibility, and suitable mechanical properties.  
Autologous endothelial outgrowth cells (EOC) were 
cultured from whole porcine blood as described in our 
previous report (Gulati R. Circ Res. 2003;93:1023-1025).  
Cells were labeled with superparamagnetic iron oxide 
nanoparticles (SPION) consisting of a magnetite core 
surrounded by a polymer shell.  Stents were crimped onto 
a delivery balloon and implanted into the right coronary 
artery of a porcine model.  Some stents were magnetized 
prior to implantation by holding in close proximity to a 
rare earth magnet and control stents were left non-
magnetized.  SPION-labeled EOCs were then delivered to 
the stented artery during 2 minutes of blood flow 
occlusion by means of an intravascular catheter.  Pigs 
were sacrificed after 1 week of implantation and stented 
arteries were histologically processed.  Magnetized stents 
were also placed within an externally applied magnetic 
field between two rare earth magnets or left unexposed to 
an externally applied magnetic field and SPION-labeled 
endothelial cells were delivered.  Photographs of cell 
capture within and without the externally applied 
magnetic field were taken using a dissection microscope. 
Results: The 2205 duplex stainless steel stents were all 
crimped and expanded without mechanical failure.  Stent 
deployment was symmetrical and resulted in minimal 
damage to the arterial wall.  Right coronary artery 
segments stented with both non-magnetized and 
magnetized stents were fully patent for all 4 pigs that 
survived to the 1 week time point.  Histological 
examination demonstrated neointimal healing over most 
of the stent struts.  Iron staining indicated the presence of 
SPION-labeled cells at the strut surface of both non-
magnetized and magnetized stents, indicating that 
delivered cells were successfully captured and retained 
under arterial blood flow conditions.  More SPION-
labeled cells were observed on the struts of magnetized 
stents when compared to non-magnetized stents (Fig. 1).   
 
   
Figure 1. Cell capture and retention (blue) to a non-
magnetized (left) and magnetized (right) stent. 
 
Some magnetic stent struts exhibited significant cell 
capture while others exhibited none, indicating non-
uniform cell capture.  This may be in part due to the 
reduction of magnetic field strength in 2205 stainless steel 
stents upon plastic deformation during expansion.  In 
addition, 2205 duplex stainless steel is only weakly 
magnetizable and the magnetic field induced within our 
stents never exceeded 1 G.  Given the weakness of the 
induced magnetic field and the significant loss of 
magnetic field strength upon stent expansion, we tested 
the hypothesis that delivering cells to an expanded stent 
within an externally applied magnetic field will result in 
enhanced cell capture.  SPION-labeled EOCs delivered to 
magnetized 2205 duplex stainless steel stents within an 
externally applied magnetic field demonstrated markedly 
better capture when compared to EOCs delivered to stents 
in the absence of an externally applied magnetic field 
(Fig. 2).  Cells were preferentially captured to bends in 
the stent struts where magnetic poles form. 
 
   
Figure 2. Cell capture (brown) without (left) and with 
(right) an externally applied magnetic field. 
 
Conclusions:  Magnetic targeting of endothelial cells to 
vascular stents is a promising means of cell capture and 
retention.  The presence of autologous endothelial cells 
may enhance healing of the stented artery and improve 
clinical outcomes.  Magnetizing stents prior to 
implantation and delivering cells without an externally 
applied magnetic field resulted in modest cell capture.  
Delivering cells in the presence of an externally applied 
magnetic field resulted in significantly enhanced cell 
capture.  Studies are currently underway to test this 
strategy in a porcine model. 
